Kv3.1 activation suppresses provoked and spontaneous seizures in a mouse Dravet syndrome model.
The Kv3.1 role is highlighted as an element of seizure control that declines after recurrent seizures and a potential novel therapeutic target for seizure control in Dravet syndrome and other epilepsies.